iShares Genomics Immunology and Healthcare ETF (IDNA)
26.94
+0.15
(+0.56%)
USD |
NYSEARCA |
Dec 24, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.47% | -0.07% | 134.80M | 24843.50 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.64% | 49.00% | -21.03M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of NYSE FactSet Global Genomics and Immuno Biopharma Index. The Fund invests at least 90% of its assets in the components of the Index, which measures the performance of equity securities issued by companies in the biopharmaceutical and healthcare equipment and services. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 25, 2025.
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.08% |
| Stock | 99.70% |
| Bond | 0.04% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.18% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of NYSE FactSet Global Genomics and Immuno Biopharma Index. The Fund invests at least 90% of its assets in the components of the Index, which measures the performance of equity securities issued by companies in the biopharmaceutical and healthcare equipment and services. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |